INTERNATIONAL PATENT: AGOMAB THERAPEUTICS NV FILES APPLICATION FOR "1,5-NAPHTYRIDINE AND QUINOLINE BASED INHIBITORS OF ALK5"

GENEVA, April 28 -- AGOMAB THERAPEUTICS NV (Posthoflei 1/62600 Antwerpen (Berchem)) filed a patent application (PCT/EP2025/080074) for "1,5-NAPHTYRIDINE AND QUINOLINE BASED INHIBITORS OF ALK5" on Oct 17, 2025. With publication no. WO/2026/082960, the details related to the patent application was published on Apr 23, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): PAMPIN CASAL, Begoña (c/o Agomab Spain S.L.U.Parque Empresarial de TouroParcelas 26-2715822 Fonte Diaz A Coruña), BALO BECERRA, Rosalino (c/o Agomab Spain S.L.U.Parque Empresarial de TouroParcelas 26-2715822 Fonte Diaz A C...